We dig into newly released Phase 2b data from Pfizers once-monthly GLP-1 candidate (formerly Metseras asset), what the results actually show, and how it stacks up in an increasingly crowded field that includes Novo Nordisk, Eli Lilly, and next-gen combination therapies
doi: 10.1007/s00125-013-2904-2 30 BielkaWPrzezakAMoledaPPius-SadowskaEMachalinskiB
Every major study shows autism is shaped by dozens of interacting factors: genes, infections, inflammation, oxidative stress, medications, and simple chance
Patel Completed her Family Medicine residency at Tallahassee Memorial
At the same time, demand for preventative care, diagnostics, and ongoing health monitoring could increase as consumers place greater emphasis on long-term wellbeing rather than acute treatment
At low concentrations, scLCDV-VILP also induced cell proliferation, but the curve was shifted one-order of magnitude to the right, peaking at 10 nM and then decreasing to basal levels with further increases in ligand, suggesting a self-inhibitory effect